53 completed, 1 terminated, 1 unknown, 1 withdrawn. 56 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 56 | Completed 53, Terminated 1, Unknown 1, Withdrawn 1 |
Follow AIDS-Related Complex: new trials by email Literature Review of AIDS-Related Complex trials Research Report on AIDS-Related Complex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs Aerosol Interferon-Gamma, Subcutaneous interferon-gamma, Placebo - Tuberculosis, AIDS-related Complex | Phase 2 | Completed | NYU Langone Health | 89 | 2005-04-01 | 2016-12-16 |
| Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. Peptide T, Placebo - HIV Infections, Cognition Disorders | Phase 2 | Completed | National Institute of Mental Health (NIMH) | 215 | 1990-01-01 | 2017-02-28 |
| A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children Azithromycin, Atovaquone, Sulfamethoxazole-Trimethoprim - Bacterial Infections, Pneumonia, Pneumocystis Carinii | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 690 | 2021-11-04 | |
| A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT Zidovudine, Zalcitabine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2021-11-04 | |
| Preventing Frequent Sinus Infections in HIV-Infected Patients Pseudoephedrine hydrochloride, Guaifenesin, Cefuroxime axetil - HIV Infections, Sinusitis | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-10-28 | ||
| A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy Delavirdine mesylate, Zidovudine, Didanosine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 471 | 2021-11-04 | |
| A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV Glycovir, Zidovudine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 210 | 2021-10-28 | |
| A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children Lamivudine, Zidovudine, Didanosine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 740 | 2011-03-02 | |
| The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease Nevirapine, Zidovudine - HIV Infections | Phase 2 | Completed | Boehringer Ingelheim | 250 | 2005-06-24 | |
| Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease Vinblastine sulfate, Dacarbazine, Filgrastim - HIV Infections, Hodgkin's Disease | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 27 | 2021-10-27 | |
| Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine Lamivudine, Stavudine, Zidovudine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 256 | 2021-11-04 | |
| Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy Lamivudine, Stavudine, Zidovudine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 280 | 2021-11-04 | |
| A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group Attenuvax, M-M-R-II - HIV Infections, Measles | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 270 | 2021-10-28 | |
| A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection Stavudine, Zidovudine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 230 | 2021-11-04 | |
| A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs Saquinavir, Lamivudine, Stavudine - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 140 | 2005-06-24 | |
| A Study of Saquinavir and Zalcitabine, Used Alone and Together, in the Treatment of Advanced HIV Infection in Patients Who Stopped Taking or Who Cannot Take Zidovudine Saquinavir, Zalcitabine - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 900 | 2005-06-24 | |
| The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks Stavudine, Zidovudine, Didanosine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 200 | 2021-11-04 | |
| The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs Lamivudine, Stavudine, Zidovudine - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 105 | 2021-11-01 | |
| The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection Saquinavir, Nevirapine, Zidovudine - HIV Infections | Phase 2 | Completed | Parexel | 225 | 2005-06-24 | |
| A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex Tumor Necrosis Factor, Interferon gamma-1b - HIV Infections | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2021-11-04 |
Showing 20 of 56. Sign in to see all of them.
HIV Infections (55) · Acquired Immunodeficiency Syndrome (41) · Cognition Disorders (2) · Pain (2) · Peripheral Nervous System Diseases (2) · AIDS-Associated Nephropathy (1) · Bacterial Infections (1) · Brain Diseases (1) · Candidiasis, Oral (1) · Chickenpox (1) · Cognitive Dysfunction (1) · Diarrhea (1) · HIV Wasting Syndrome (1) · Herpes Zoster (1)
Blood-Borne Infections (56) · Communicable Diseases (56) · Genital Diseases (56) · Immune System Diseases (56) · Immunologic Deficiency Syndromes (56) · Infections (56) · Lentivirus Infections (56) · RNA Virus Infections (56) · Retroviridae Infections (56) · Sexually Transmitted Diseases (56) · Sexually Transmitted Diseases, Viral (56) · Slow Virus Diseases (56) · Urogenital Diseases (56) · Virus Diseases (56) · Pathological Conditions, Signs and Symptoms (4)
Zidovudine (25) · Zalcitabine (12) · Didanosine (11) · Lamivudine (6) · Stavudine (6) · Saquinavir (5) · Nevirapine (4) · celgosivir (2) · Acyclovir (1) · Amitriptyline (1) · Amphotericin B (1) · Atovaquone (1) · Azithromycin (1) · Beclomethasone (1) · Benztropine (1)
National Institute of Allergy and Infectious Diseases (NIAID) (35) · Hoffmann-La Roche (4) · Hoechst Marion Roussel (3) · Glaxo Wellcome (2) · AJI Pharma USA (1) · Biocodex (1) · Boehringer Ingelheim (1) · Genelabs Technologies (1) · Immunobiology Research Institute (1) · Mylan Laboratories (1) · NYU Langone Health (1) · National Institute of Mental Health (NIMH) (1) · Neurex (1) · Parexel (1) · Pharmacia and Upjohn (1)
United States (56) · Puerto Rico (17) · Tanzania (5) · Canada (2) · South Africa (1)
Corey L (3) · Fischl MA (3) · Friedland G (3) · Pollard R (3) · Richman D (3) · Coombs R (2) · Hammer S (2) · Havlir D (2) · Katzenstein D (2) · BJ Luft (1) · Bryson Y (1) · Cavert W (1) · Chandwani S (1) · Collier A (1) · Collier AC (1)
R01HL059832 (1)